H.R. 1526 · 118th Congress · House

Reducing Hereditary Cancer Act

Active· Referred to the Subcommittee on Health.
Introduced
Mar 9, 23
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Reducing Hereditary Cancer Act

This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

Action Timeline

6
  1. DEC 17, 2024•Committee

    Referred to the Subcommittee on Health.

  2. MAR 17, 2023•Committee

    Referred to the Subcommittee on Health.

  3. MAR 09, 2023•IntroReferral

    Introduced in House

  4. MAR 09, 2023•IntroReferral

    Introduced in House

  5. MAR 09, 2023•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  6. MAR 09, 2023•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committees

4

Health Subcommittee

hswm02

Referred: Dec 17, 2024

Active

Health Subcommittee

hsif14

Referred: Mar 17, 2023

Active

Ways and Means Committee

hswm00

Referred: Mar 9, 2023

Active

Energy and Commerce Committee

hsif00

Referred: Mar 9, 2023

Active